Disclosures: Khalid Aloum: Nothing to Disclose, Amr Dokmak: Nothing to Disclose, Wendy Tatiana Garzon-Siatoya: Nothing to Disclose, Abdellatif Ismail: Nothing to Disclose, Camelia Ciobanu: Nothing to Disclose, Jeeva Jaganathan: Nothing to Disclose, Praneeth Bandaru: Nothing to Disclose, Ali Wakil: Nothing to Disclose, Arnold Nongmoh Forlemu: Nothing to Disclose, Vijay Bhaskar Reddy Gayam: Nothing to Disclose, Vikash Kumar: Nothing to Disclose, Raissa Nana Sede Mbakop: Nothing to Disclose, Lisnaldy Ramirez: Nothing to Disclose, Manasa Ginjupalli: Nothing to Disclose, Denzil Etienne: Nothing to Disclose, Nithan Narendra: Nothing to Disclose, Madhavi Reddy: Nothing to Disclose 1055 UTILIZING FIB-4 AND TRANSIENT ELASTOGRAPHY TO DIAGNOSE STEATOTIC LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES: QUALITY IMPROVEMENT PROJECT AT A VETERANS AFFAIRS RESIDENT CLINIC Nimmy Thomas 1 Christina Stull 1 Holli Sadler 2 , 1 UT Austin Dell Medical School, 2 Central Texas Veterans Affairs Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common cause of chronic liver disease and is the leading cause of liver-related morbidity and mortality
In the chronic wound model of diabetes, MOF/Gel can continuously regulate the local oxidative stress level and promote the natural transition from the inflammatory phase to the proliferative phase
Lan CC, Wu CS, Huang SM, Kuo HY, Wu IH, Liang CW, et al
3800-C PATIENT PREFERENCES FOR HEPATOCELLULAR CARCINOMA SCREENING ATTRIBUTES Karissa D
